Publications

2026

Cases, M., Imre, A., Giles, R., Puga, L., Piggin, M., Geissler, J., Racovita, M., di Priolo, S. L., Wogu, L., Hyseni-Bocolli, A., Morgan, K., Hosszú, D., Pitter, J., Ágh, T., Plate, A. (2026). Variation in Use of PROMs and Geographical Distribution in Clinical Trials of Selected Haematological Diseases in Europe. Blood Global Hematology. Doi: 10.1016/j.bglo.2026.100107 Link

Choon-Quinones, M., Obeng, G. D., Asiedu-Ayeh, B., Kawuo, S., Tukur, A. M., Mohammed, I., Obeng, A.P., Harousseau, J-L., Seckinger, A., Hose, D., Sarkodie, E., Imre, A., Csanádi, M. (2026). Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025. European Journal of Haematology. Doi: 10.1111/ejh.70133 Link

Dóczi, T. I., Vaghela, S., Obeng, G. D., Ameyaw, D., Zelei, T., Vokó, Z., Sikirica, V., Varga, O., Kovács, G., Józwiak-Hagymásy, J., Perera, S. (2026). Epidemiology of Hyperphenylalaninemia: A Systematic Review and Meta-Analysis. Sage Open Pediatrics. Doi: 10.1177/30502225251414610 Link

Grisay, G., Turco, F., Patrikidou, A., Gallardo, E., McDermott, R., Briers, E., Fournier, B., Basova, O., Dhont, B., Csanádi, M., Gillessen, S., Tombal, B. (2026). EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer. European Urology doi: 10.1016/j.eururo.2026.07.020 Link

Gyöngyösi, K., Petykó, Zs. I., Hosszú, D., Pantziarka, P., van der Meer, H. G., Lo, D. C., Csanádi, M., Obeng, G. D., Kaló, Z., Inotai, A. (2026). Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challenges. Health Policy OPEN. doi: 10.1016/j.hpopen.2026.100168 Link

Huić, M., Erčević, D., Saghy, E., Grenković, R., Tandara Haček, R., Vajagić, M., Predavec, S., Csanádi, M., Pitter, J. G., Čivljak, M., Poklepović Peričić, T., Puljak, L., Utrobičić, A., Rutten-van Mölken, M., Zemplényi, A. T. (2026). Added value of a specialized mobile palliative care team compared to the usual care in the primary care setting of Croatia: a 3-month prospective cohort study. BMC Palliative Care. Doi: 10.1186/s12904-026-02239-1 Link

Imre, A., Mészáros, Á., Németh, B., Nagy, B., Józwiak-Hagymásy, J., Cecere, G., Homan, P., Sommer, I. E. C., Babarczy, B. (2026). The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data. Health Economics Review. Doi: 10.1186/s13561-026-00766-4 Link

Imre, A., Nagy, B., Hren, R. (2026). Assessing the Early Economic Feasibility of a Curative Gene Therapy for Multiple Sclerosis Using a Risk-Adjusted Valuation Framework. Healthcare. doi: 10.3390/healthcare14050674 Link

Imre, A., Németh, B., Józwiak, Á., Nagy, B., Balkányi, L., Fasseeh, A. N., Kaló, Z., Zemplényi, A. (2026). From General-Purpose Models to Purpose-Built Artificial Intelligence Systems for Health Economic Modeling. Expert Review of Pharmacoeconomics & Outcomes Research. doi:10.1080/14737167.2026.2717289. Link

Imre, A., Tímár, G., Ancona, A., Alfieri, F., Perpignano, E., Jászkuti, B., Nagy, B., Németh, B., Kaló, Z. (2026). Early cost-effectiveness analysis of the U-Care Renal Platform. BMC Nephrology. Doi: 10.1186/s12882-026-05289-y Link

Józwiak, Á., Imre, A., Hagymásy, J., Tittmann, J., Nagy, Á., Kovács, S., Kardas, P., van Boven, J.F.M., Mommers, I., Tamás Ágh (2026). REFLECTIVE-TIAB: Cost-Effective Prompt Optimization for Large Language Model-Based Title and Abstract Screening in Literature Reviews. Expert Review of Pharmacoeconomics & Outcomes Research. Doi: 10.1080/14737167.2026.2691995 Link

Varga, O., Ferrante, G., Vokó, Z., Széles, G., Heijnsdijk, E. A. M., Ivanuš, U., Senore, C., Csanádi, M. (2026). Improving EU cancer screening policies: A framework for identifying barriers of screening programs with monitoring data. Journal of Cancer Policy. doi: 10.1016/j.jcpo.2026.100755 Link

2025

Achterbosch, M., Aksoy, N., Obeng, G. D., Ameyaw, D., Ágh, T., van Boven, J. F. M. (2025). Clinical and economic consequences of medication nonadherence: a review of systematic reviews. Frontiers in Pharmacology. doi: 10.3389/fphar.2025.1570359 Link

Alimohamed, M.Z., Obeng, G.D., Csanadi, M., Masimirembwa, C., Dandara, C. (2025). Implementing health economics for pharmacogenomics research translation in Africa. Communications Medicine. Doi: 10.1038/s43856-025-00955-y Link

Cases, M., Imre, A., Giles, R. H., Puga, L., Piggin, M., Geissler, J., Racovita, M., Leto di Priolo, S., Wogu, L. R., Hyseni-Bocolli, A., Morgan, K., Hosszú, D., Józwiák, Á., Ágh, T., Plate, A. & EuroACT Working Group (2025). Geographic Inequities in Patient-Reported Outcome Measures in Clinical Trials of Selected Solid Tumours in Europe: Findings from EuroACT. Available at SSRN. doi: 10.2139/ssrn.5390471 Link

Cases, M., Imre, A., Giles, R. H., Puga, L., Piggin, M., Geissler, J., Racovita, M., Leto di Priolo, S., Wogu, L. R., Hyseni-Bocolli, A., Morgan, K., Hosszú, D., Pitter, J. G., Ágh, T., Plate, A. (2025). Variation in Use of Patient-Reported Outcome Measures and in Geographical Distribution in Clinical Trials of Selected Malignant and Non-Malignant Haematological Diseases in Europe: Findings from EuroACT. Available at SSRN. doi: 10.2139/ssrn.5646744 Link

Choon-Quinones, M., Obeng, G. D., Ágh, T., Imre, A., Asiedu-Ayeh, B., Kawuo, S., Tukur, A. M., Mohammed, I., Obeng, A. P., Durie, B., Harousseau, J.-L., Seckinger, A., Hose, D., Csanádi, M. (2025). CO198 Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response. Value in Health. doi: 10.1016/j.jval.2025.04.283 Link

Csanádi, M., Filipi, K., Ylli, A., Dedja, B., Bejko, A., Kovacevic, I. N., Vukovic-Lekovic, J., Stanisic, M., Vujovic, A., Obeng, G. D., de Kok, I. M. C. M., Vokó, Z., Varga, O. (2025). Barriers of organized cervical cancer screening in Albania and Montenegro. BMC Public Health. doi: 10.1186/s12889-025-22535-4 Link

DiStefano, M. J., McQueen, R. B., Zheng, H., Gyamfi, H. G., Ameyaw, D., Campbell, J. D., Zemplenyi, A. (2025). Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation Program. Applied Health Economics and Health Policy. doi: 10.1007/s40258-025-01009-z Link

Fasseeh, A. N., Ashmawy, R., Hren, R., ElFass, K., Imre, A., Németh, B., Nagy, D., Nagy, B., & Vokó, Z. (2025). Generating Realistic Synthetic Patient Cohorts: Enforcing Statistical Distributions, Correlations, and Logical Constraints. Algorithms. doi: 10.3390/a18080475 Link

Imre, A., Hosszú, D., Bögös, A., Nagy, B., Józwiak-Hagymásy, J., Ágh, T., Józwiak, Á. B. (2025). P36 Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma. Value in Health. doi: 10.1016/j.jval.2025.04.049 Link

Imre, A., Mészáros, Á., Németh, B., Nagy, B., Józwiak-Hagymásy, J., Cecere, G., Homan, P., Sommer, I. E. C., Babarczy, B. (2025). The Global Economic Burden of Schizophrenia: An Umbrella Review of Systematic Reviews and Meta-Analyses. medRxiv. Doi: 10.1101/2025.06.13.25329410 Link

Imre, A., Nagy, B., Hren, R. (2025). Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. British Journal of Clinical Pharmacology. doi: 10.1002/bcp.70204 Link

Józwiak-Hagymásy, J., Széles, Á., Dóczi, T., Németh, B., Mezei, D., Varga, H., Gronchi, A., van Houdt, W. J., Tordai, A., Csanádi, M. (2025). Economic evaluations and health economic models of soft tissue sarcomas: Systematic literature review from a European and North American perspective. Critical Reviews in Oncology/Hematology. 10.1016/j.critrevonc.2025.104661 Link

Kaló, Z., Imre, A., Tatár, M., Nagy, B. (2025). Early-stage assessment of investigational digital technologies in mental health: a guidance for innovators. Psychiatry Research. doi:10.1016/j.psychres.2025.116634 Link

Kaló, Z., Imre, A., Varga, G., Kovács, S., Tímár, Gy., Nagy, B. (2025). Optimization of pharmaceutical research and development by early-phase assessment of investigational medicinal products. British Journal of Clinical Pharmacology. doi: 10.1002/bcp.70192 Link

Mikhael, J., Darlington, D., Howell, B., Hydren, J., Hernandez, T., Werner, S., Iraca, T., Arnett, M., Gonzalez, V., Peschin, S., Balch, A. J., Moran, D., Young-Daniels, R., Banjo, O., Obeng, G. D., Asiedu-Ayeh, B., Kawuo, S., Tukur, A. M., Mohammed, I., Obeng, A. P., Csanádi, M., Lew, T., Choon-Quinones, M. (2025). The benefits of telehealth in promoting equity in blood cancer care – results of a multi-stakeholder forum and narrative review. Journal of Medical Economics. doi: 10.1080/13696998.2024.2438561 Link

Nguyen, T. T., Ameyaw, D., Obeng, G. D., Amuah, R., Józwiak-Hagymásy, J., Dóczi, T., Mezei, D., Németh, B., Tordai, A., Alanya, A., Grisay, G., Csanádi, M. (2025). Systematic Literature Review on Economic Evaluations and Health Economic Models in Metastatic Castration-Sensitive Prostate Cancer. Current Oncology. doi: 10.3390/curroncol32080412 Link

Országh, E., Józwiak-Hagymásy, J., Dóczi, T., Mezei, D., Németh, B., Varga, H., Tordai, A., Kazda, T., Gorlia, T., Quoilin, C., Preusser, M., Minniti, G., Csanádi, M. (2025). Methodological aspects of economic evaluations and health economic models in glioblastoma: A systematic literature review, Neuro-Oncology Practice. Doi: https://doi.org/10.1093/nop/npaf113 Link

Petykó, Z. I., Hosszú, D., Csanádi, M., Gyöngyösi, K., Obeng, G. D., Ameyaw, D., Dóczi, T. I., Kaló, Z., Lo, D. C., van der Meer, H. G., Pantziarka, P., Inotai, A. (2025). The eyes of the beholder: Perceived barriers to successful drug repurposing. British Journal of Pharmacology. doi: 10.1111/bph.70243 Link

Puga, L., Cases Escute, M., Imre, A., Giles, R., Piggin, M., Leto di Priolo, S., Racovita, M., Ruth Wogu, L., Geissler, J., Hosszú, D., Józwiak, Á., Ágh, T., Pitter, J., Plate, A. (2025). 2309P European atlas on clinical trials in cancer and haematology (EuroACT): Mapping research and equity across Europe. Annals of Oncology. Doi:10.1016/j.annonc.2025.08.2925 Link

2024

Imre, A., Babarczy, B., Mészáros, Á., Németh, B., Nagy, B. (2024). EE194 Economic Burden of Schizophrenia: An Umbrella Review of Direct and Indirect Costs. Value in Health. doi: 10.1016/j.jval.2024.10.478 Link

Kovačević, I. N., Vujović, A., Stanišić, M., Vuković-Leković, J., Lansdorp-Vogelaar, I., Mlakar, D. N., Senore, C., Józwiak-Hagymásy, J., Széles, Gy., Vokó, Z., Csanádi, M. (2024). Roadmap to improve the organized cancer screening programs – The case of colorectal cancer screening in Montenegro. Journal of Cancer Policy. doi:10.1016/j.jcpo.2023.100464 Link

Nguyen, T.T., Ameyaw, D., Obeng, G.D., Amuah, R., Józwiak-Hagymásy, J., Dóczi, T., Mezei, D., Németh, B., Tordai, A., Alanya, A., Grisay, G., Csanádi, M. (2024). SA50 Systematic Literature Review on Economic Evaluations and Health Economic Models in the Field of Metastatic Castration-Sensitive Prostate Cancer. Value in Health. doi: 10.1016/j.jval.2024.10.3131 Link

Preusser, M., Kazda, T., Le Rhun, E., Sahm, F., Smits, M., Gempt, J., Koekkoek, J. A.F., Monti, A. F., Csanadi, M., Pitter, J. Gy., Bulbek, H., Fournier, B., Quoilin, C., Gorlia, T., Weller, M., Minniti, G., on behalf of the European Organisation for Research, Treatment of Cancer (EORTC) Brain Tumor Group (2024). Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study. Trials. Doi: 10.1186/s13063-024-08213-7 Link

Sebek, M, Jánosov, M., Ruppert, P., Józwiak-Hagymásy, J., Szeles, G., Mészáros, Á., Országh, E., Zentai, A., Gyimesi, L., Józwiak, Á.B., Barabási, A.L. (2024). MSR185 Creating European Foodome Knowledge Graph to Capture the Dark Matter of Nutrition. Value in Health. doi: 10.1016/j.jval.2024.10.2419 Link

2023

Babarczy, B., Józwiak-Hagymásy, J., Ameyaw, D., Obeng, G. D., Zelei, T., Szeles, G., Banerjee, G., Sikirica, V. (2023). EE702 Humanistic and Economic Burden of Methylmalonic Acidemia—A Systematic Literature Review. Value in Health. doi: 10.1016/j.jval.2023.09.967 Link

Ispán, F., Hegedüs, T., Csanádi, M., Nagy, B. (2023). A kockázatmegosztási megállapodások adminisztrációs terhei Magyarországon – Irány az automatizáció? – Administrative burden of managed entry agreements for pharmaceuticals in Hungary – towards automation?. IME. doi: 10.53020/IME-2023-407 Link

Lorenzovici, L., Szilberhorn, L., Farkas-Ráduly, S. Gasparik, A. I., Precup, A. M., Nagy, A. Gy., Niemann, C. U., Aittokallio, T., Kaló, Z., Csanádi, M. (2023). Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs. doi: 10.1007/s40259-023-00583-9 Link

Nagy, B., Győrbíró, D., Csanádi, M. (2023). A kis dózisú komputertomográfiával történő tüdőrákszűrés hazai bevezetésének kérdései. LEGE ARTIS MEDICINAE. doi: 10.33616/lam.33.0105 Link

Tittmann, J., Csanádi, M., Ágh, T., Széles, Gy., Vokó, Z., Kallai, Á. (2023). Development of a breast cancer screening protocol to use automated breast ultrasound in a local setting. Frontiers in Public Health. doi: 10.3389/fpubh.2022.1071317 Link

Zielonke, N., Senore, C., Ponti, A., Csanádi, M., de Koning, H. J., Heijnsdijk, E. A. M., van Ravesteyn, N. T. (2023). Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy. Journal of Medical Screening. doi:10.1177/09691413231153568 Link

2022

Ágh, T., Szilberhorn, L., Csanádi, M., Széles, G., Vokó, Z., Ádám, G., Kallai, Á. (2022). A kis sugárdózisú komputertomográfia szerepe a tüdőrákszűrésben. Orvosi Hetilap. doi: 10.1556/650.2022.32583 Link

Csanádi, M., Ágh, T., Tordai, A., Tapprich, C., Vokó, Z., Stamatopoulos, K. (2022). Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review. Expert Review of Hematology. doi: 10.1080/17474086.2022.2042246 Link

Csanádi, M., Kaló, Z., Rutten-van Molken, M., Looman, W., Huic, M., Ercevic, D., Atanasijevic, D., Lorenzovici, L., Petryszyn, P., Pogány, G., Pitter, J., Zemplényi, A. (2022). Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries. Health Policy. doi: 10.1016/j.healthpol.2022.08.012. Link

Elek, P., Csanádi, M., Fadgyas-Freyler, P., Gervai, N., Oross-Bécsi, R., Szécsényi-Nagy, B., Tatár, M., Váradi, B., Zemplényi, A. (2022). Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models. BMJ Open. doi: 10.1136/bmjopen-2022-061941 Link

Elek, P., Fadgyas-Freyler, P., Váradi, B., Mayer, B., Zemplényi, A., Csanádi, M. (2022). Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. doi: 10.1016/j.healthpol.2022.05.013 Link

Farkas-Ráduly, Sz., Csanádi, M., Ágh, T., Szász, O.,Vokó, Z., Széles, Gy. (2022). A digitális technológia kínálta új lehetőségek a melanoma malignum szűrésében. Szakirodalmi áttekintés [New opportunities offered by digital technology in melanoma malignum screening.]. Orvosi Hetilap. doi: 10.1556/650.2022.32613 Link

Fasseeh, A. N., Saragih, S. M., Hayek, N., Brodovska, S., Ismail, ElShalakani, A. A., Abaza, S., Obeng, G. D., Ameyaw, D., Kalo, Z. (2022). Impact of Health Technology Assessment Implementation with Special Focus on Middle-Income Countries. Health Policy and Technology. doi: 10.1016/j.hlpt.2022.100688 Link

Gervai, N., Szécsényi-Nagy, B., Zemplényi, A., Csanádi, M., Kollányi, Zs. (2022). A társadalom járványkezelési intézkedésekkel kapcsolatos adherenciájának rendszerszemléletű vizsgálata (Adherence towards public health interventions during the COVID-19 pandemic – lessons from system dynamics). Népegészségügy. Link

Lorenzovici, L., Bârzan-Székely, A., Farkas-Ráduly, Sz., Pana, B.C., Csanádi, M., Chiriac, N.D., Kaló, Z. (2022). Burden of Chronic Heart Failure in Romania. Healthcare. doi: 10.3390/healthcare10010107 Link

Main, B., Csanádi, M., Ozieranski, P. (2022). Pricing strategies, executive committee power and negotiation leverage in New Zealand’s containment of public spending on pharmaceuticals. Health Economics, Policy & Law. doi: 10.1017/S1744133122000068 Link

Mayer, B., Tóth, M., Csanádi, M., Zemplényi, A., Fadgyas-Freyler, P., Oross-Bécsi, R., Elek, P., Szécsényi-Nagy, B. (2022). A COVID-19 világjárvány hatása a daganatos betegek ellátására (The impact of the COVID-19 pandemic on cancer care). Népegészségügy. Link

Németh, B., Csanádi, M., Inotai, A., Ameyaw, D., Kaló, Z. (2022). Access to high-priced medicines in lower-income countries in the WHO European Region. World Health Organization. Regional Office for Europe. License: CC BY-NC-SA 3.0 IGO Link

Pitter, J. G., Moizs, M., Somogyiné Ezer, É., Lukács, G., Szigeti, A., Repa, I., Csanádi, M., Rutten-van Mölken, M. P. M. H., Islam, K., Kaló, Z., Vokó, Z. (2022). Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control. PLOS ONE. doi: 10.1371/journal.pone.0276719 Link

Tittmann, J., Csanádi, M., Ágh, T., Széles, Gy., Vokó, Z., Ormándi, K., Kallai, Á. (2022). Az automatizált emlőultrahang-daganatszűrés szakirodalmi áttekintése. Orvosi Hetilap. doi: 10.1556/650.2022.32565 Link

2021

Babela, R., Orsagh, A., Ricova, J., Lansdorp-Vogelaar, I., Csanádi, M., De Koning, H., Reckova, M. (2021). Cost-effectiveness of colorectal cancer screening in Slovakia. European Journal of Cancer Prevention. doi: 10.1097/CEJ.0000000000000727 Link

Gini, A., Buskermolen, M., Senore, C., Anttila, A., Novak Mlakar, D., Veerus, P., Csanádi, M., Jansen, E. E. L., Zielonke, N., Heinävaara, S., Széles, G., Segnan, N., de Koning, H. J., & Lansdorp-Vogelaar, I. (2021). Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe. MDM Policy & Practice. doi:10.1177/2381468320984974 Link

Gini, A., van Ravesteyn, N. T., Jansen, E. E. L., Heijnsdijk, E. A. M., Senore, C., Anttila, A., Mlakar, D. N., Veerus, P., Csanádi, M., Zielonke, N., Heinävaara, S., Széles, Gy., Segnan, N., de Koning, H. J., Lansdorp-Vogelaar, I. (2021). The EU-TOPIA Evaluation Tool: An Online Modelling–Based Tool for Informing Breast, Cervical, and Colorectal Cancer Screening Decisions in Europe. Preventive Medicine Reports. doi: 10.1016/j.pmedr.2021.101392 Link

Ozieranski, P., Pitter, J.G., Rickard. E., Mulinari, S., Csanadi, M. (2021). A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding. Sociology of Health & Illness. doi: 10.1111/1467-9566.13409 Link

Pogány, G., Csanádi, M., Bódy, É., Bojtor, Zs., Kereki, J., Fadgyas-Freyler, P., Szabó, L., Kaló, Z. (2021). Bizonyítékokon alapuló egészségpolitikai döntéshozatal az integrált ellátásban – A Ritka Betegségek Nemzeti Erőforrás Központjának tervezési folyamata. Orvosi Hetilap. doi: 10.1556/650.2021.32244 Link

Zemplényi, A. T., Csikós, Á., Fadgyas-Freyler, P., Csanádi, M., Kaló, Z., Pozsgai, É., Rutten-van Mölken, M., Pitter, J. Gy. (2021). Early Palliative Care Associated with Lower Costs for Adults with Advanced Cancer: Evidence From Hungary. European Journal of Cancer Care. doi: 10.1111/ecc.13473 Link

2020

Csanádi, M., Ágh, T., Farkas-Ráduly, S., Gros, B., Tapprich, C., Trudeau, J. J., Lipton, J. H., & Mattsson, J. (2020). Patient-reported Symptom Burden of Chronic Graft Versus Host Disease: A Systematic Literature Review. Expert Review of Hematology. doi: 10.1080/17474086.2020.1818065 Link

Csanádi, M., Gini, A., Koning, H., Széles, G., Pitter, J.G., Oroszi, B., Pataki, P., Fadgyas-Freyler, P., Korponai, G., Vokó, Z., Lansdorp-Vogelaar, I. (2020). Modeling Costs and Benefits of the Organized Colorectal Cancer Screening Programme and Its Potential Future Improvements in Hungary. Journal of Medical Screening. doi:10.1177/0969141320968598 Link

Ozieranski, P., Csanádi, M., Rickard, E., Mulinari, E. (2020). Under-Reported Relationship: A Comparative Study of Pharmaceutical Industry and Patient Organisation Payment Disclosures in the UK (2012–2016). BMJ Open. 2020 Sep 19;10(9):e037351. doi: 10.1136/bmjopen-2020-037351. Link

Rais, C., Kaló, Z., Csanádi, M., Negulescu, V. (2020). Current and future perspectives for the implementation of health technology assessment in Romania. Health Policy and Technology, 9(1), 45-52. doi: 10.1016/j.hlpt.2019.11.007 Link

Zemplényi, A. T., Csikós, Á., Csanádi, M., Mölken, M. R.-v., Hernandez, C., Pitter, J. G., Czypionka, T., Kraus, M., & Kaló, Z. (2020). Implementation of palliative care consult Service in Hungary – integration barriers and facilitators. BMC Palliative Care, 19(1). doi:10.1186/s12904-020-00541-0 Link

Zemplényi, A. T., Csikós, Á., Fadgyas-Freyler, P., Csanádi, M., Kaló, Z., Pozsgai, É., Rutten-van Mölken, M., & Pitter, J. G. (2020). Care Integration Decreases Hospitalization Costs: Retrospective Cohort Study of Palliative Care Consult Service for Hospital Patients With Metastatic Cancer. doi:10.21203/rs.3.rs-41113/v1 Link

2019

Agh, T., Csanadi, M., Voko, Z., Webb, T., Jeyakumaran, D., Trudeau, J., Sengupta, N., Schain, F., Mattsson, J. (2019). Humanistic burden of patients with chronic graft-versus-host disease-systematic literature review of health-related quality of life and functional status. Expert Review of Hematology, 12(5), 295-309. doi: 10.1080/17474086.2019.1602036 Link

Csanadi, M., Agh, T., Tordai, A., Webb, T., Jeyakumaran, D., Sengupta, N., Schain, F., Mattsson, J. (2019). A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert Review of Hematology, 12(5), 311-323. doi: 10.1080/17474086.2019.1605288 Link

Csanádi, M., Inotai, A., Oleshchuk, O., Lebega, O., Alexandra, B., Piniazhko, O., Németh, B., Kaló, Z. (2019). Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives. International Journal of Technology Assessment in Health Care, 35(5), 393-400. doi: 10.1017/s0266462319000679 Link

Csanádi, M., de Kok, I. M. C. M., Heijnsdijk, E. A. M., Anttila, A., Heinävaara, S., Pitter, J. G., Széles, G., Ivanuš, U., Priaulx, J., Veerus, P., Senore, C., Koning, H. J. d., Vokó, Z. (2019). Key indicators of organized cancer screening programs: Results from a Delphi study. Journal of Medical Screening, 26(3), 120-126. doi: 10.1177/0969141318820362 Link

Csanádi, M., Ozierański, P., Löblová, O., King, L., Kaló, Z., Botz, L. (2019). Shedding light on the HTA consultancy market: Insights from Poland. Health Policy, 123(12), 1237-1243. doi: 10.1016/j.healthpol.2019.08.008 Link

Harsányi, A., Csanádi, M., Márky, K., Vincziczki, Á. Z., Kaló, Z., Inotai, A. (2019). Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary. Expert Review of Pharmacoeconomics & Outcomes Research, 1-7. doi: 10.1080/14737167.2019.1667232 Link

Kaló, Z., van den Akker, L. H. M., Vokó, Z., Csanádi, M., Pitter, J. G. (2019). Is there a fair allocation of healthcare research funds by the European Union? PLOS ONE, 14(4), e0207046. doi:10.1371/journal.pone.0207046 Link

Lukács, G., Kovács, Á., Csanádi, M., Moizs, M., Repa, I., Kaló, Z., Vokó, Z., Pitter, J. G. (2019). Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence. Cancer Management and Research, Volume 11, 9849-9861. doi:10.2147/cmar.s221427. Link

Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L., McKee, M. (2019). Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology. Health Policy, 123(7), 630-634. doi: 10.1016/j.healthpol.2019.05.012 Link

Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L., McKee, M. (2019). Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. Health Policy, 123(8), 713-720. doi: 10.1016/j.healthpol.2019.05.021 Link

Pitter, J. G., Csanádi, M., Szigeti, A., Lukács, G., Kovács, Á., Moizs, M., Repa, I., Zemplényi, A., Czypionka, T., Kraus, M., Rutten-van Mölken, M. P. M. H., Kaló, Z. (2019). Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a qualitative study. BMC Health Services Research, 19(1). doi: 10.1186/s12913-019-3957-9 Link

2018

Csanádi, M., Löblová, O., Ozierański, P., Harsányi, A., Kaló, Z., McKee, M., King, L. (2018). When health technology assessment is confidential and experts have no power: the case of Hungary. Health Economics, Policy and Law, 14(2), 162-181. doi: 10.1017/s1744133118000051 Link

Csanádi, M., Kaló, Z., Prins, C. P. J., Grélinger, E., Menczelné Kiss, A., Fricke, F.-U., Fuksa, L., Tesar, T., Manova, M., Lorenzovici, L., Vokó, Z., Garrison, L. P. (2018). The implications of external price referencing on pharmaceutical list prices in Europe. Health Policy and Technology, 7(3), 243-250. doi: 10.1016/j.hlpt.2018.07.005 Link

Inotai, A., Csanadi, M., Petrova, G., Dimitrova, M., Bochenek, T., Tesar, T., York, K., Fuksa, L., Kostyuk, A., Lorenzovici, L., Omelyanovskiy, V., Egyed, K., Kalo, Z. (2018). Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International, 2018, 1-9. doi: 10.1155/2018/9597362 Link

Ozierański, P., Löblová, O., Nicholls, N., Csanádi, M., Kaló, Z., McKee, M., King, L. (2018). Transparency in practice: Evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015. Health Economics, Policy and Law, 14(2), 182-204. doi: 10.1017/s1744133117000342 Link

Pitter, J. G., Lukács, G., Csanádi, M., Vokó, Z. (2018). Clinical impact of treatment delay in pancreatic cancer patients revisited. International Journal of Cancer, 142(12), 2621-2622. doi: 10.1002/ijc.31263 Link

Priaulx, J., Csanádi, M., de Koning, H. J., McKee, M. (2018). A choice experiment to identify the most important elements of a successful cancer screening program according to those who research and manage such programs. The International Journal of Health Planning and Management, 34(1), e34-e45. doi: 10.1002/hpm.2697 Link

Priaulx, J., de Koning, H. J., de Kok, I. M. C. M., Széles, G., McKee, M. (2018). Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty-one European countries using the Barriers to Effective Screening Tool (BEST). Health Policy, 122(11), 1190-1197. doi: 10.1016/j.healthpol.2018.08.004 Link

Turnbull, E., Priaulx, J., de Kok, I. M. C. M., Lansdorp-Vogelaar, I., Anttila, A., Sarkeala, T., Senore, C., Segnan, N., Csanádi, M., Pitter, J., Novak Mlakar, D., Ivanus, U., Veerus, P., de Koning, H. J., McKee, M. (2018). Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries. Health Policy, 122(11), 1206-1211. doi: 10.1016/j.healthpol.2018.08.005 Link

2017

Inotai, A., Csanádi, M., Harsányi, A., Németh, B. (2017). Drug Policy in Hungary. Value in Health Regional Issues, 13, 16-22. doi: 10.1016/j.vhri.2017.06.003 Link

Inotai, A., Csanadi, M., Vitezic, D., Francetic, I., Tesar, T., Bochenek, T., Lorenzovici, L., Dylst, P., Kalo, Z. (2017). Policy Practices to Maximise Social Benefit from Biosimilars. Journal of Bioequivalence & Bioavailability, 09(04). doi: 10.4172/jbb.1000346 Link

Inotai, A., Prins, C. P. J., Csanádi, M., Vitezic, D., Codreanu, C., Kaló, Z. (2017). Is there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars. Expert Opinion on Biological Therapy, 17(8), 915-926. doi: 10.1080/14712598.2017.1341486 Link

Németh, B., Csanádi, M., Kaló, Z. (2017). Overview on the current implementation of health technology assessment in the healthcare system in Hungary. International Journal of Technology Assessment in Health Care, 33(3), 333-338. doi: 10.1017/s0266462317000071 Link

Rosselli, D., Quirland-Lazo, C., Csanádi, M., Ruiz de Castilla, E. M., González, N. C., Valdés, J., Abicalaffe, C., Garzón, W., Leon, G., Kaló, Z. (2017). HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status. Value in Health Regional Issues, 14, 20-27. doi: 10.1016/j.vhri.2017.02.004 Link

2016

Glonti, K., Pitter, J., Csanadi, M., Vokó, Z., McKee, M. (2016). Health system factors associated with uptake of cancer screening: an overview of systematic reviews. European Journal of Public Health, 26(suppl_1). doi: 10.1093/eurpub/ckw169.068 Link

Inotai, A., Csanadi, M., Agh, T. (2016). Real-world data analysis to improve drug policy decision-making in Central Eastern European countries. [in Hungarian] IME INTERDISZCIPLINARIS MAGYAR EGESZSEGUGY 15: 47-52. Link

Kaló, Z., Gheorghe, A., Huic, M., Csanádi, M., Kristensen, F. B. (2016). HTA Implementation Roadmap in Central and Eastern European Countries. Health Economics, 25, 179-192. doi: 10.1002/hec.3298 Link

2012

Szigethy, E., Széles, G., Horváth, A., Hidvégi, T., Jermendy, G., Paragh, G., Blaskó, G., Ádány, R., Vokó, Z. (2012). Epidemiology of the metabolic syndrome in Hungary. Public Health, 126(2), 143-149. doi: 10.1016/j.puhe.2011.11.003 Link

2011

Petrovski, B. É., Széles, G., Melles, M., Pataki, V., Kardos, L., Jenei, T., Ádány, R., Vokó, Z. (2011). Behaviour does not fully explain the high risk of chronic liver disease in less educated men in Hungary. European Journal of Public Health, 21(5), 662-666. doi: 10.1093/eurpub/ckq079 Link

2009

Voko, Z., Csepe, P., Nemeth, R., Kosa, K., Kosa, Z., Szeles, G., Adany, R. (2009). Does socioeconomic status fully mediate the effect of ethnicity on the health of Roma people in Hungary? Journal of Epidemiology & Community Health, 63(6), 455-460. doi: 10.1136/jech.2008.079715 Link